Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin dosing strategies for chronic prostatitis
NCT00402688Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Nov 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levofloxacin in chronic prostatitis (CP) (3 arms), sponsored by Johnson & Johnson. Primary endpoint: Clinical Success. Started Nov 2006; status: completed.
02
Drugs
levofloxacin
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on NCT00402688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402688.